SIRION Biotech Expands North American Presence by Opening New Site at Cambridge, MA.

SIRION Biotech GmbH News Releases

Find the latest News from SIRION Biotech GmbH

Page 3 of 4
SIRION Biotech Expands North American Presence by Opening New Site at Cambridge, MA.
SIRION Biotech Expands North American Presence by Opening New Site at Cambridge, MA. Learn More >
SIRION Biotech strengthens USA links with new partnership and manufacturing site
SIRION Biotech strengthens USA links with new partnership and manufacturing site Learn More >
New success for SIRION Biotech vaccination candidate Ad19a/64
New success for SIRION Biotech vaccination candidate Ad19a/64 Learn More >
SIRION Biotech’s new vaccination candidate successful in Ad5 pre-immunization in-vivo study
SIRION Biotech’s new vaccination candidate successful in Ad5 pre-immunization in-vivo study Learn More >
SIRION Biotech presenting advanced viral vectors and BOOSTER technology at ELRIG Drug Discovery ’16
SIRION Biotech presenting advanced viral vectors and BOOSTER technology at ELRIG Drug Discovery ’16 Learn More >
SIRION Biotech pioneering work on lentiviral vectors recognized in prestigious new scientific volume
SIRION Biotech pioneering work on lentiviral vectors recognized in prestigious new scientific volume Learn More >
SIRION Biotech expands business and ideas
SIRION Biotech expands business and ideas Learn More >
SIRION Biotech announces preclinical vaccination success
SIRION Biotech announces preclinical vaccination success Learn More >
SIRION Biotech promote progress of novel breakthrough vaccines at BIO-Europe
SIRION Biotech promote progress of novel breakthrough vaccines at BIO-Europe Learn More >
SIRION Biotech bringing latest viral vector insights to ELRIG Drug Discovery ’15
SIRION Biotech bringing latest viral vector insights to ELRIG Drug Discovery ’15 Learn More >
Viral vector specialist SIRION Biotech heading to ECC2015 Vienna
Viral vector specialist SIRION Biotech heading to ECC2015 Vienna Learn More >
Research confirms superiority of SIRION Biotech’s AAV vectors and Lentivirus strategies
Research confirms superiority of SIRION Biotech’s AAV vectors and Lentivirus strategies Learn More >
Page 3 of 4